Answers are grounded in this paper and cite their sources.
How inherited genetic variation propagates through multicellular regulatory systems to influence human disease remains poorly understood. To reconstruct the regulatory architecture of genetic variation on circulating immune cells, we analysed single-cell transcriptomes from 6.7 million peripheral blood mononuclear cells from 4,452 European-ancestry UK Biobank participants, identifying 114,063 independent cis-regulatory effects affecting 15,419 genes. Using a new statistical workflow (FLANDERS), we map the hierarchical organisation of these effects and the underlying regulatory architecture across tissues, immune lineages, cell types and cell states. We find that disease-associated variants predominantly act through regulatory programmes shared within immune lineages and broad cellular compartments, rather than through highly specific cellular states. We show that local cis -regulatory effects commonly act through coherent regulatory pathways implicating transcription factor cascades and intercellular signalling, which allows linking together multiple disease genes. We demonstrate independent support for these genes and mechanisms through rare variant associations. Our findings reveal a highly organised structure of immune regulatory variation shaping human disease, and provide a highly effective framework for interpreting disease associations and prioritising therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Pirastu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: